Biocon’s Bengaluru Biosimilars Plant Cleared For EU

Company Expands Production Capacity For Pegfilgrastim And Trastuzumab

 
• By Akriti Seth
  
GMP concept cell background 3d illustration
After receiving GMP approval for its manufacturing sites, Biocon will further focus on EU markets • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business